Sleep disorders in patients with multiple sclerosis

Sleep Medicine Reviews

Volumn 14, Issue 2, 2010, Pages 121-129

  Brass, Steven D ^a   Duquette, Pierre ^b   Proulx Therrien, Joëlle ^b   Auerbach, Sanford ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Excessive daytime sleepiness; Fatigue; Insomnia; Multiple sclerosis; Obstructive sleep apnea syndrome; Restless legs syndrome; Sleep

Indexed keywords

4 AMINOPYRIDINE; AMANTADINE; BACLOFEN; BETA INTERFERON; CLONAZEPAM; CYTOKINE; GABAPENTIN; METHYLPHENIDATE; METHYLPREDNISOLONE; MODAFINIL; OXYBUTYNIN; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE;

BEHAVIOR DISORDER; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORRELATION ANALYSIS; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DROWSINESS; FATIGUE; HUMAN; INSOMNIA; MULTIPLE SCLEROSIS; NARCOLEPSY; PREVALENCE; QUALITY OF LIFE; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SOMNOLENCE;

EID: 75849132917     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2009.07.005     Document Type: Review

References (108)

1. Multiple Sclerosis Society America. Frequently asked questions [Internet]. [cited 02/24/2009]. Available from: (2009). http://www.msassociation.org/faq/#question-6
2. Tachibana N., Howard R.S., Hirsch N.P., Miller D.H., Moseley I.F., and Fish D. Sleep problems in multiple sclerosis. Eur Neurol 34 6 (1994) 320-323
3. Stanton B.R., Barnes F., and Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler 12 4 (2006) 481-486
4. Merlino G., Fratticci L., Lenchig C., Valente M., Cargnelutti D., Picello M., et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med 10 1 (2009) 26-34
5. Kaynak H., Altintaş A., Kaynak D., Uyanik O., Saip S., Aǧaoǧlu J., et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol 13 12 (2006) 1333-1339
6. Attarian H.P., Brown K.M., Duntley S.P., Carter J.D., and Cross A.H. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol 61 4 (2004) 525-528
7. Bamer A.M., Johnson K.L., Amtmann D., and Kraft G.H. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler 14 8 (2008) 1127-1130
8. Kripke D.F., Garfinkel L., Wingard D.L., Klauber M.R., and Marler M.R. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59 2 (2002) 131-136
9. Patel S.R., and Redline S. Two epidemics: are we getting fatter as we sleep less?. Sleep 27 4 (2004) 602-603
10. Ayas N.T., White D.P., Al-Delaimy W.K., Manson J.E., Stampfer M.J., Speizer F.E., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26 2 (2003) 380-384
11. Ayas N.T., White D.P., Manson J.E., Stampfer M.J., Speizer F.E., Malhotra A., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163 2 (2003) 205-209
12. American Academy of Sleep Medicine. In: Winkleman J., Kotagal S., Olson E., Scammel T., and Schenk C. (Eds). International classification of sleep disorders: diagnostic and coding manual. 2nd ed. (2005), American Academy of Sleep Medicine, Westchester, IL
13. Hublin C., Kaprio J., Partinen M., Koskenvuo M., Heikkila K., Koskimies S., et al. The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol 35 6 (1994) 709-716
14. Iseki K., Mezaki T., Oka Y., Terada K., Tomimoto H., Miki Y., et al. Hypersomnia in MS. Neurology 59 12 (2002) 2006-2007
15. Berg O., and Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand 39 (1963) 252-256
16. Nishino S., and Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9 4 (2005) 269-310
17. Schrader H., Gotlibsen O.B., and Skomedal G.N. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 30 1 (1980) 105-108
18. Vetrugno R., Stecchi S., Plazzi G., Lodi R., D'Angelo R., Alessandria M., et al. Narcolepsy-like syndrome in multiple sclerosis. Sleep Med 10 (2009) 389-391
19. Younger D.S., Pedley T.A., and Thorpy M.J. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology 41 3 (1991) 447-448
20. Poirier G., Montplaisir J., Dumont M., Duquette P., Décary F., Pleines J., et al. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 37 4 (1987) 693-695
21. Oka Y., Kanbayashi T., Mezaki T., Iseki K., Matsubayashi J., Murakami G., et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol 251 7 (2004) 885-886
22. Duquette P., Décary F., Pleines J., Boivin D., Lamoureux G., Cosgrove J.B., et al. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 12 2 (1985) 106-110
23. Caples S.M., Gami A.S., and Somers V.K. Obstructive sleep apnea. Ann Intern Med 142 3 (2005) 187-197
24. Clanet M.G., and Brassat D. The management of multiple sclerosis patients. Curr Opin Neurol 13 3 (2000) 263-270
25. Ferini-Strambi L., Filippi M., Martinelli V., Oldani A., Rovaris M., Zucconi M., et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 125 2 (1994) 194-197
26. Trojan DA, Da Costa D, Bar-Or A, Benedetti A, Lapierre Y, Arnold DL et al. Sleep abnormalities in multiple sclerosis patients. Mult Scler 2008;14: S160.
27. Ajayi OF, Chang-McDowell T, Culpepper II WJ, Royal W, Bever CT. High prevalence of sleep disorders in veterans with multiple sclerosis. Neurology 2008;50:P06.141
28. Arnulf I., and Derenne J.P. Respiratory disorders during sleep in degenerative diseases of the brain stem. Rev Neurol 157 11 Pt 2 (2001) S148-S151
29. Howard R.S., Wiles C.M., Hirsch N.P., Loh L., Spencer G.T., and Newsom-Davis J. Respiratory involvement in multiple sclerosis. Brain 115 Pt 2 (1992) 479-494
30. Stankiewicz J.A., and Pazevic J.P. Acquired Ondine's curse. Otolaryngol Head Neck Surg 101 5 (1989) 611-613
31. Severinghaus J.W., and Mitchell R.A. Ondine's curse - failure of respiratory center automaticity while awake. Clin Res 10 (1962) 122
32. Chaudhary B.A., Elguindi A.S., and King D.W. Obstructive sleep apnea after lateral medullary syndrome. South Med J 75 1 (1982) 65-67
33. Askenasy J.J., and Goldhammer I. Sleep apnea as a feature of bulbar stroke. Stroke 19 5 (1988) 637-639
34. Auer R.N., Rowlands C.G., Perry S.F., and Remmers J.E. Multiple sclerosis with medullary plaques and fatal sleep apnea (Ondine's curse). Clin Neuropathol 15 2 (1996) 101-105
35. Levin B.E., and Margolis G. Acute failure of automatic respirations secondary to a unilateral brainstem infarct. Ann Neurol 1 6 (1977) 583-586
36. Nogués M.A., Roncoroni A.J., and Benarroch E. Breathing control in neurological diseases. Clin Auton Res 12 6 (2002) 440-449
37. Rizvi S.S., Ishikawa S., Faling L.J., Schlessinger L., Satia J., and Seckel B. Defect in automatic respiration in a case of multiple sclerosis. Am J Med 56 4 (1974) 433-436
38. Chervin R.D., and Guilleminault C. Diaphragm pacing: review and reassessment. Sleep 17 2 (1994) 176-187
39. Chervin R.D., and Guilleminault C. Diaphragm pacing for respiratory insufficiency. J Clin Neurophysiol 14 5 (1997) 369-377
40. Bassetti C.L., and Gugger M. Sleep disordered breathing in neurologic disorders. Swiss Med Wkly 132 9-10 (2002) 109-115
41. Tippmann-Peikert M., Boeve B.F., and Keegan B.M. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 66 8 (2006) 1277-1279
42. Ohayon M.M. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 31 3 (1997) 333-346
43. Ohayon M.M., Caulet M., and Priest R.G. Violent behavior during sleep. J Clin Psychiatry 58 8 (1997) 369-376 quiz 377
44. Plazzi G., and Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med 3 5 (2002) 437-439
45. Gómez-Choco M.J., Iranzo A., Blanco Y., Graus F., Santamaria J., and Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler 13 6 (2007) 805-808
46. Gagnon J.F., Postuma R.B., and Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology 67 5 (2006) 742-747
47. Taphoorn M.J., van Someren E., Snoek F.J., Strijers R.L., Swaab D.F., Visscher F., et al. Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol 240 7 (1993) 446-448
48. Scammell T.E., Estabrooke I.V., McCarthy M.T., Chemelli R.M., Yanagisawa M., Miller M.S., et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20 22 (2000) 8620-8628
49. Sack R.L., Auckley D., Auger R.R., Carskadon M.A., Wright K.P., Vitiello M.V., et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 30 11 (2007) 1460-1483
50. Ekbom K.A. Restless legs syndrome. Neurology 10 (1960) 868-873
51. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003;4:101-119.
52. Hening W.A., Allen R.P., Chaudhuri K.R., Hornyak M., Lee H.B., Winkelman J., et al. Clinical significance of RLS. Mov Disord 22 Suppl. 18 (2007) S395-S400
53. Auger C., Montplaisir J., and Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology 65 10 (2005) 1652-1653
54. Manconi M., Fabbrini M., Bonanni E., Filippi M., Rocca M., Murri L., et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol 14 5 (2007) 534-539
55. Manconi M., Rocca M.A., Ferini-Strambi L., Tortorella P., Agosta F., Comi G., et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler 14 1 (2008) 86-93
56. Deriu M., Cossu G., Molari A., Murgia D., Mereu A., Ferrigno P., et al. Restless legs syndrome in multiple sclerosis: a case-control study. Mov Disord 24 (2009) 697-701
57. Moreira N.C.V., Damasceno R.S., Medeiros C.A.M., de Bruin P.F.C., Teixeira C.A.C., Horta W.G., et al. Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients. Braz J Med Biol Res 41 10 (2008) 932-937
58. Michaud M., Paquet J., Lavigne G., Desautels A., and Montplaisir J. Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol 48 2 (2002) 108-113
59. Schormair B., Kemlink D., Roeske D., Eckstein G., Xiong L., Lichtner P., et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 40 8 (2008) 946-948
60. Allen R.P., and Earley C.J. The role of iron in restless legs syndrome. Mov Disord 22 Suppl. 18 (2007) S440-S448
61. Brass S.D., Chen N.K., Mulkern R.V., and Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 17 1 (2006) 31-40
62. Wetter T.C., Collado-Seidel V., Pollmächer T., Yassouridis A., and Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23 3 (2000) 361-367
63. Wesstrom J., Nilsson S., Sundstrom-Poromaa I., and Ulfberg J. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 11 5 (2008) 422-428
64. Italian REMS Study Group, Manconi M., Ferini-Strambi L., Filippi M., Bonanni E., Iudice A., et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep 31 7 (2008) 944-952
65. Schutte-Rodin S., Broch L., Buysse D., Dorsey C., and Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4 5 (2008) 487-504
66. Ancoli-Israel S., and Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 22 Suppl. 2 (1999) S347-S353
67. Valiquette G., Herbert J., and Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol 53 12 (1996) 1270-1275
68. O'Connor A.B., Schwid S.R., Herrmann D.N., Markman J.D., and Dworkin R.H. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137 1 (2008) 96-111
69. Clark C.M., Fleming J.A., Li D., Oger J., Klonoff H., and Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol 49 6 (1992) 641-643
70. Kapsimalis F., Basta M., Varouchakis G., Gourgoulianis K., Vgontzas A., and Kryger M. Cytokines and pathological sleep. Sleep Med 9 6 (2008) 603-614
71. Payne L.C., and Krueger J.M. Interactions of cytokines with the hypothalamus-pituitary axis. J Immunother 12 3 (1992) 171-173
72. Krueger J.M., Obál F.J., Fang J., Kubota T., and Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 933 (2001) 211-221
73. Cavadini G., Petrzilka S., Kohler P., Jud C., Tobler I., Birchler T., et al. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci U S A 104 31 (2007) 12843-12848
74. Payne L.C., Obál F., and Krueger J.M. Hypothalamic releasing hormones mediating the effects of interleukin-1 on sleep. J Cell Biochem 53 4 (1993) 309-313
75. Obál F., Fang J., Payne L.C., and Krueger J.M. Growth-hormone-releasing hormone mediates the sleep-promoting activity of interleukin-1 in rats. Neuroendocrinology 61 5 (1995) 559-565
76. Opp M.R., and Krueger J.M. Anti-interleukin-1 beta reduces sleep and sleep rebound after sleep deprivation in rats. Am J Physiol 266 3 Pt 2 (1994) R688-R695
77. Opp M.R., Smith E.M., and Hughes T.K. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J Neuroimmunol 60 1-2 (1995) 165-168
78. Kushikata T., Fang J., Wang Y., and Krueger J.M. Interleukin-4 inhibits spontaneous sleep in rabbits. Am J Physiol 275 4 Pt 2 (1998) R1185-R1191
79. Heesen C., Nawrath L., Reich C., Bauer N., Schulz K.H., and Gold S.M. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?. J Neurol Neurosurg Psychiatry 77 1 (2006) 34-39
80. Heesen C., Koehler G., Gross R., Tessmer W., Schulz K.H., and Gold S.M. Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue. Mult Scler 11 1 (2005) 51-57
81. Hauser S.L., Doolittle T.H., Lincoln R., Brown R.H., and Dinarello C.A. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40 11 (1990) 1735-1739
82. Heesen C., Gold S.M., Raji A., Wiedemann K., and Schulz K.H. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinology 27 4 (2002) 505-517
83. Bourne R.S., and Mills G.H. Sleep disruption in critically ill patients-pharmacological considerations. Anaesthesia 59 4 (2004) 374-384
84. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 4th ed. (2005), Saunders [Text with Continually Updated Online Reference]
85. Kotterba S., Eren E., Fangerau T., Malin J.P., and Sindern E. Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments. Fortschr Neurol Psychiatr 71 11 (2003) 590-594
86. MacAllister W.S., and Krupp L.B. Multiple sclerosis-related fatigue. Phys Med Rehabil Clin N Am 16 2 (2005) 483-502
87. Krupp L.B., Alvarez L.A., LaRocca N.G., and Scheinberg L.C. Fatigue in multiple sclerosis. Arch Neurol 45 4 (1988) 435-437
88. Bakshi R., Shaikh Z.A., Miletich R.S., Czarnecki D., Dmochowski J., Henschel K., et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6 3 (2000) 181-185
89. Bakshi R., Miletich R.S., Henschel K., Shaikh Z.A., Janardhan V., Wasay M., et al. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 53 5 (1999) 1151-1153
90. Lapierre Y., and Hum S. Treating fatigue. Int MS J 14 2 (2007) 64-71
91. Durmer J.S., and Dinges D.F. Neurocognitive consequences of sleep deprivation. Semin Neurol 25 1 (2005) 117-129
92. Benbadis S.R., Mascha E., Perry M.C., Wolgamuth B.R., Smolley L.A., and Dinner D.S. Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population. Ann Intern Med 130 4 Pt 1 (1999) 289-292
93. Chervin R.D. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest 118 2 (2000) 372-379
94. Strober L.B., and Arnett P.A. An examination of four models predicting fatigue in multiple sclerosis. Arch Clin Neuropsychol 20 5 (2005) 631-646
95. Culebras A. Other neurological disorders. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 883. Available at: www.sleepmedtext.com
96. Markowitz C.E. Interferon-beta: Mechanism of action and dosing issues. Neurology 68 (2007) S8-S11
97. Schweitzer P.K. Drugs that disturb sleep. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 509-11. Available at: www.sleepmedtext.com
98. Sioka J.S. The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Multiple Sclerosis 11 4 (2005) 425-432
99. Mitler M.M., and O'Malley M.B. Wake-promoting medications: efficacy and adverse effects. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 488-9. Available at: www.sleepmedtext.com
100. Nishino S., and Mignot E. Wake-promoting medications: basic mechanisms and pharmacology. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 468-76. Available at: www.sleepmedtext.com
101. Korenke A.R. Sustained-Release Fampridine for Symptomatic Treatment of Multiple Sclerosis. The Annals of Pharmacotherapy 42 10 (2008) 1458-1465
102. Mignot E. Narcolepsy: pharmacology, pathophysiology, and genetics. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 763-5. Available at: www.sleepmedtext.com
103. Finnimore A.J., et al. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 8 (1995) 230-234
104. Mendelson W.B. Hypnotic medications: mechanisms of action and pharmacology effects. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 449-51. Available at: www.sleepmedtext.com
105. Tanaka H., et al. Effects of tizanidine for refractory sleep disturbance in disabled children with spastic quadriplegia. No To Hattatsu 36 6 (2004) 455-460
106. Schweitzer P.K. Drugs that disturb sleep. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 499-504. Available at: www.sleepmedtext.com
107. Buysse D.J., Schweitzer P.K., and Moul D.E. Clinical pharmacology of other drugs used as hypnotics. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. 4th ed (2005), WB Saunders, Philadelphia. p. 459-64. Available at: www.sleepmedtext.com
108. Diefenbach K., et al. Randomised, double blind study of the effects of oxybutynin, toiterodine, trospium chloride and placebo on sleep in healthy young volunteers. Clinical drug investigation 23 6 (2003) 395-404